OVIVAC P PLUS

Država: Irska

Jezik: angleščina

Source: HPRA (Health Products Regulatory Authority)

Kupite ga zdaj

Lastnosti izdelka Lastnosti izdelka (SPC)
12-06-2017
DSU DSU (DSU)
20-10-2023

Aktivna sestavina:

Clostridium perfringens type d, strain 603 epsilon toxoid; Clostridium septicum s1110/85 toxoid; Clostridium tetani, strain 51123/91 toxoid; Clostridium chauvoei strain no. 655; Clostridium chauvoei strain no. 656; Clostridium chauvoei strain no. 657; Clostridium chauvoei strain no. 658; Clostridium chauvoei strain no. 1048; Formalin killed cells of mannheimia haemolytica serotypes a1; Formalin killed cells of mannheimia haemolytica serotypes a2; Formalin killed cells of mannheimia haemolytica serotypes a6; Formalin killed cells of mannheimia haemolytica serotypes a7; Formalin killed cells of mannheimia haemolytica serotypes a9; Formalin killed cells of pasteurella trehalosi serotypes t3; Formalin killed cells of pasteurella trehalosi serotypes t4; Formalin killed cells of pasteurella trehalosi serotypes t10; Formalin pasteurella trehalosi strain t15 (s1105/84)

Dostopno od:

Intervet Ireland Limited

Koda artikla:

QI04AB05

INN (mednarodno ime):

Clostridium perfringens type d, strain 603 epsilon toxoid; Clostridium septicum s1110/85 toxoid; Clostridium tetani, strain 51123/91 toxoid; Clostridium chauvoei strain no. 655; Clostridium chauvoei strain no. 656; Clostridium chauvoei strain no. 657; Clostridium chauvoei strain no. 658; Clostridium chauvoei strain no. 1048; Formalin killed cells of mannheimia haemolytica serotypes a1; Formalin killed cells of mannheimia haemolytica serotypes a2; Formalin killed cells of mannheimia haemolytica serotypes a6; Formalin killed cells of mannheimia haemolytica serotypes a7; Formalin killed cells of mannheimia haemolytica serotypes a9; Formalin killed cells of pasteurella trehalosi serotypes t3; Formalin killed cells of pasteurella trehalosi serotypes t4; Formalin killed cells of pasteurella trehalosi serotypes t10; Formalin pasteurella trehalosi strain t15 (s1105/84)

Odmerek:

.

Farmacevtska oblika:

Suspension for injection

Tip zastaranja:

LR: Licensed Retailer as defined in national legislation

Terapevtska skupina:

Sheep

Terapevtsko območje:

clostridium + pasteurella

Terapevtske indikacije:

Immunological - Inactivated Vaccine

Status dovoljenje:

Authorised

Datum dovoljenje:

2003-03-21

Lastnosti izdelka

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
OVIVAC P PLUS
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For the full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Suspension for injection
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Sheep and lambs from 3 weeks of age.
ACTIVE SUBSTANCES
per ml
_Clostridium perfringens_ type D_,_ strain 603 epsilon toxoid
inducing
5 IU
_Clostridium septicum_ S1110/85 toxoid
inducing
2.5 IU
_Clostridium tetani,_ strain 51123/91 toxoid
inducing
2.5IU
_Clostridium chauvoei_ cells and equivalent toxoid of strains
655,656,657,658, 1048. inducing
0.5 guinea pig PD
90
Formalin killed cells of_ Mannheimia haemolytica_ serotypes
A1
5 x 10
8
cells
A2
5 x 10
8
cells
A6
5 x 10
8
cells
A7
5 x 10
8
cells
A9
5 x 10
8
cells
Formalin killed cells of_ Pasteurella trehalosi_ serotypes
T3
5 x 10
8
cells
T4
5 x 10
8
cells
T10
5 x 10
8
cells
T15
5 x 10
8
cells
ADJUVANT
Aluminium hydroxide gel
400
mg
EXCIPIENTS
Thiomersal (preservative)
0.067 - 0.15 mg
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_9_
_/_
_0_
_9_
_/_
_2_
_0_
_1_
_6_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_4_
_7_
_1_
_8_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the active immunisation of sheep to reduce mortality and clinical
signs of pulpy kidney, tetanus, braxy and blackleg
caused by_ Clostridium perfringens_ type D,_ Cl. tetani, Cl.
septicum_, and_ Cl. chauvoei_ and to reduce mortality and
clinic
                                
                                Preberite celoten dokument
                                
                            

Podobni izdelki

Ogled zgodovine dokumentov